SEHK:2269Life Sciences
WuXi Biologics Awards And Earendil Deal Shape Biologics Valuation Story
WuXi Biologics (Cayman) (SEHK:2269) received six company awards and two individual awards at the 2026 Asia Pacific Biopharma Excellence Awards.
The company entered a collaboration with Earendil Labs to co develop multiple novel antibody and antibody drug conjugate therapeutics.
For investors tracking contract research, development and manufacturing organizations, WuXi Biologics sits at the center of global demand for outsourced biologics work. The new Asia Pacific awards span development,...